Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

PaperCitations, authors & open-access status

Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 90 citations, 2021 year and hybrid oa status.

90
Citations
2021
Year
hybrid
OA Status

Related on ScholarIQ

Gerhard Bogner
Author
Gynecologic Oncology
Journal
PARP inhibition in cancer therapy
Topic
PARP inhibition in cancer therapy
Topic
Ovarian cancer diagnosis and treatment
Topic
Toxin Mechanisms and Immunotoxins
Topic
470M+ articles · free account